Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lingyi Zhang

Showing results (141-150 of 149) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 149 results.
The Pharmacogenomics Journal|January 22, 2022
A single nucleotide polymorphism-based formula to predict the risk of propofol TCI concentration being over 4 µg mL<sup>-1</sup> at the time of loss of consciousnessZhuoling Zheng, Faling Xue, Haini Wang, et al.
Journal of Autoimmunity|June 6, 2024
Prevalence and clinical profiles of primary sclerosing cholangitis in China: Data from electronic medical records and systematic literature retrievalXiaoqian Xu, Tongtong Meng, Lichen Shi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2020
Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal StudyYuxi Yi, Lijun Shen, Wei Shi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 14, 2025
The Optimal Cutoffs of Liver Stiffness Measurement for Staging Fibrosis in On-treatment Patients With Chronic Hepatitis BXiaoning Wu, Jialing Zhou, Yameng Sun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 1, 2023
Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related EventsYameng Sun, Wei Chen, Shuyan Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 4, 2026
Peginterferon α-2b Enhances HBsAg Loss in NA-Suppressed Low-HBsAg Chronic Hepatitis B Patients: Everest Study in ChinaChan Xie, Bingliang Lin, Zhishuo Mo, et al.
Journal of Clinical and Translational Hepatology|January 10, 2020
Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis BShan Shan, Hong You, Junqi Niu, et al.
Clinical and Translational Medicine|April 22, 2024
ATF3 is a neuron-specific biomarker for spinal cord injury and ischaemic strokeJonathan Z Pan, Zhanqiang Wang, Wei Sun, et al.
Journal of Hepatology|May 21, 2021
The Chinese Society of Hepatology position statement on the redefinition of fatty liver diseaseYuemin Nan, Jihong An, Jianfeng Bao, et al.
Pageof 15

Showing results (141-150 of 149) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 149 results.
The Pharmacogenomics Journal|January 22, 2022
A single nucleotide polymorphism-based formula to predict the risk of propofol TCI concentration being over 4 µg mL<sup>-1</sup> at the time of loss of consciousnessZhuoling Zheng, Faling Xue, Haini Wang, et al.
Journal of Autoimmunity|June 6, 2024
Prevalence and clinical profiles of primary sclerosing cholangitis in China: Data from electronic medical records and systematic literature retrievalXiaoqian Xu, Tongtong Meng, Lichen Shi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 2020
Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: A Prospective, Longitudinal StudyYuxi Yi, Lijun Shen, Wei Shi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 14, 2025
The Optimal Cutoffs of Liver Stiffness Measurement for Staging Fibrosis in On-treatment Patients With Chronic Hepatitis BXiaoning Wu, Jialing Zhou, Yameng Sun, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 1, 2023
Regression of Liver Fibrosis in Patients on Hepatitis B Therapy Is Associated With Decreased Liver-Related EventsYameng Sun, Wei Chen, Shuyan Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 4, 2026
Peginterferon α-2b Enhances HBsAg Loss in NA-Suppressed Low-HBsAg Chronic Hepatitis B Patients: Everest Study in ChinaChan Xie, Bingliang Lin, Zhishuo Mo, et al.
Journal of Clinical and Translational Hepatology|January 10, 2020
Baseline Characteristics and Treatment Patterns of the Patients Recruited to the China Registry of Hepatitis BShan Shan, Hong You, Junqi Niu, et al.
Clinical and Translational Medicine|April 22, 2024
ATF3 is a neuron-specific biomarker for spinal cord injury and ischaemic strokeJonathan Z Pan, Zhanqiang Wang, Wei Sun, et al.
Journal of Hepatology|May 21, 2021
The Chinese Society of Hepatology position statement on the redefinition of fatty liver diseaseYuemin Nan, Jihong An, Jianfeng Bao, et al.
Pageof 15